The 2C T-cell transgenic mouse: An in vivo model of allospecific cytotoxic T-cell activation and homing

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 779-

  Stegall, M D ^a   Elices, M ^b   Shepard, G ^c   Gup, C ^c   Ninova, D ^a   Ferguson, D ^a   Gill, R G ^c  

^a MAYO CLINIC   (United States)

^b CYTEL CORPORATION   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CS1 P; FIBRONECTIN; IMMUNOSUPPRESSIVE AGENT; INTEGRIN; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; GRAFT SURVIVAL; LYMPHOCYTE HOMING; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; GRAFT SURVIVAL; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFUSION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, LYMPHOCYTE HOMING; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0344457187     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01761-8     Document Type: Conference Paper

References (5)

1. Isobe M., Suzuki J., Yagita H., et al. Transplant Proc. 26:1994;867.
2. Orosz C.G., Ohye R.G., Pelletier R.P., et al. Transplantation. 56:1993;453.
3. Stegall M.D., Ostrowska A., Hanes J., et al. Surgery. 118:1995;366.
4. Wahl S.M., Allen J.B., Hines K.L., et al. J Clin Invest. 94:1994;655.
5. Coito A.J., Korom S., Graser E., et al. Transplantation. 65:1998;699.